Skip to main content

How Epilepsy Medication, drugs and New anti-epileptics pills are Beneficial MRFR current research on epilepsy


Epilepsy Market 2019 Industry Size, Key Highlights, Growth Analysis, Clinical Therapeutics, Competitive Share, Regional Scope and Forecast To 2023

new epilepsy medications 2019 Market Research on The global Epilepsy Market has been dominated by key players such as –

Johnson & Johnson
Pfizer Inc.
Abbott
UCB Pharma Ltd.
GlaxoSmithKline plc
Sanofi
Novartis AG
Cephalon Inc.
Shire Pharmaceuticals Limited
and Others

Globally, the EpilepsyMarket has been segmented based on region, generation, and types of seizures.
The global epilepsy market is segmented by condition, diagnosis & treatment, and end-user. According to the Brain Injury Association of Michigan, brain injury is one of the main causes noticed in 40% cases of epilepsy. Rise in number of road accidents in developed economies can support the fact. Rise in partial epilepsy seizures resulting from brain injuries is another market driver. The spike in neurological disorders such as depression and Parkinson’s is predicted to fuel the epilepsy market growth. According to the National Center for Biotechnology Information, the number of cases of Alzheimer’s among the elderly in 2017 was recorded at 80% and it can increase exponentially.

 Epilepsy Drug Regional Analysis

Geographically, the Americas leads the worldwide market for epilepsy market on account of the growing incidents of epilepsy, availability of the advanced technologies, along with the enhanced healthcare infrastructure within the region. The Centers for Disease Control and Prevention stated in their reports that during 2015, 1.2% of the total U.S. populace suffered from active epilepsy. Additionally, it had been projected that, in the US, the annual sum of indirect and direct worth of epilepsy was around USD 15.5 billion. Europe holds the second share in the market owing to increasing healthcare outlays, surging healthcare R&D spending by the governing bodies, and rapid patient population. 

Labels:

Comments

Post a Comment

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...
3 comments
Read more

Krabbe Disease Treatment Market Set to Surge Significantly with New Innovations, Application, Recent Technology

  Krabbe Disease Treatment Market Overview Krabbe disease is an incurable medical condition where the protective coating of nerve cells around the brain are destroyed which causing nerve damage. The global Krabbe disease treatment market can reach a significant valuation, exhibiting a steady CAGR over the forecast period of 2016 to 2022, as per a research report published by Market Research Future (MRFR). The market has been growing continuously on account of increasing incidence of Krabbe disease across the globe. Classification of Krabbe disease under orphan disease has propelled the growth of the market. Pharmaceutical companies receive incentives to develop medicine for rare disease along with reduced fees in protocol assistance and protection from competition after the medicine is marketed. Increased government funding for drug development and easy approvals, tax credits on clinical research, reduction in the amount of registration fees also aid the growth of the market. These...
Post a Comment
Read more

Healthcare Analytics Market Emerging Trends and Technology Enhancements Research Report 2020

Healthcare Analytics Market Research Report: By Type (Predictive, Cognitive), Component (Software, Services), Delivery Model (On-Premise), Application (Financial Analytics, Clinical Analytics), End User (Payers, Hospitals)- Global Forecast till 2024 Healthcare Analytics Market report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report The report presents a detailed analysis of  Healthcare Analytics Market  by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current imp...
Post a Comment
Read more